Home |Register |Login |Company Information
Our Company
Order Publications
Advertisers
Customer Service
|Survey |Help
Search MPR Database:

The most widely used drug reference by clinicians
Therapeutic Categories Brand Generic Manufacturer News
Drug News
New Products
Resources
Alerts (Sponsored)
Clinical Charts
Prescribing Notes
Manufacturer Index
empr Download We've Got Answers

New Product Releases

July 18, 2008
  • Kinrix
July 11, 2008
  • Pentacel
July 3, 2008
  • Lexiscan
June 27, 2008
  • Entereg
June 20, 2008
  • Relistor
June 12, 2008
  • Ferralet 90
June 6, 2008
  • Cimzia
May 30, 2008
  • Treximet
May 22, 2008
  • Patanase
May 16, 2008
  • Treanda
May 9, 2008
  • Omnaris
May 2, 2008
  • Pristiq
April 25, 2008
  • Evamist
April 17, 2008
  • Arcalyst
April 11, 2008
  • Totect
April 4, 2008
  • Simcor 500/20
March 27, 2008
  • Triesence
March 21, 2008
  • Renvela
March 14, 2008
  • Ibudone 5/200
March 7, 2008
  • Intelence
February 29, 2008
  • Tekturna HCT 150/12.5
February 21, 2008
  • Flector Patch
February 14, 2008
  • Fosteum
February 7, 2008
  • Recothrom
January 31, 2008
  • Voltaren Gel
January 25, 2008
  • Veregen
January 17, 2008
  • Bystolic
January 10, 2008
  • Kuvan
January 4, 2008
  • Calomist
December 27, 2007
  • Combigan
December 20, 2007
  • Tasigna
December 13, 2007
  • Ixempra
December 6, 2007
  • Isentress
November 29, 2007
  • Doribax
November 21, 2007
  • Afluria
November 15, 2007
  • Torisel
November 8, 2007
  • Endometrin
November 1, 2007
  • Azor
September 25, 2007
  • Perforomist
  • Selzentry
  • Xyzal
August 24, 2007
  • Azasite
August 1, 2007
  • Divigel
  • Exforge 5/160
  • Lybrel
June 27, 2007
  • Neupro
  • Pylera
  • Symbicort 160/4.5
  • Vyvanse
May 25, 2007
  • Altabax
  • Elestrin
  • Reclast
  • Veramyst
May 7, 2007
  • Tykerb
May 2, 2007
  • » Fexmid
  • Janumet
March 28, 2007
  • Brovana
  • Tekturna
February 21, 2007
  • Implanon
  • Lialda
January 31, 2007
  • Invega
  • Pataday
January 4, 2007
  • Angeliq
  • Tyzeka
  • Ziana
Archived Products »

FEXMID Rx

Fexmid

Cyclobenzaprine 7.5mg dose available

Company:

Victory Pharma

Pharmacologic class:

Muscle relaxant (central)

Active ingredient:

Cyclobenzaprine 7.5mg, tabs.

Indication:

Acute muscle spasms, as an adjunct to rest and physical therapy.

Adults:

≥15yrs: initially 5mg 3 times daily, may increase to 7.5mg or 10mg 3 times daily; max 2–3 weeks. Elderly or hepatic impairment: consider less frequent dosing.

Children:

<15yrs: not recommended.

Contraindications:

During or within 14 days of MAOIs. Acute post-MI. Arrhythmias, heart block, other conduction disturbances. CHF. Hyperthyroidism.

Precautions:

Hepatic impairment (if moderate to severe: not recommended). Urinary retention. Angle-closure glaucoma. Increased intraocular pressure. Elderly. Pregnancy (Cat.B). Nursing mothers.

Interactions:

See Contraindications. Hypertensive crisis with MAOIs. Potentiates anticholinergics, alcohol, other CNS depressants. May antagonize guanethidine, clonidine. Tramadol increases seizure risk.

Adverse reactions:

Drowsiness, dry mouth, dizziness, fatigue, headache, GI upset, irritability, nervousness, asthenia, blurred vision, confusion.

How supplied:

Tabs—100

Last Updated:

5/3/07

From Haymarket Media, Inc. the Publishers of:
Monthly Prescribing Reference Nurse Practitioners' Prescribing Reference Physician Assistants' Prescribing Reference
Cortlandt Forum McKnight's Long-Term Care News Renal & Urology News The Clinical Advisor JAAPA McKnight's Assisted Living
HonCode
© Copyright 2008 | All Rights Reserved. | Disclaimer | Privacy Policy | Site Map | Print Subscription Questions | Online Acct. Help | Subscribe
Haymarket Publishing